This is the classic website, which will be retired eventually. Please visit the modernized instead.
Working… Menu

Immune Globulin Subcutaenous (Human), 20%

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01412385
Recruitment Status : Completed
First Posted : August 9, 2011
Last Update Posted : May 5, 2021
Information provided by (Responsible Party):
Takeda ( Baxalta now part of Shire )

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : May 13, 2014
Actual Study Completion Date : May 13, 2014